APA (7th ed.) Citation

Shen, J., Zhang, J., Zhu, Z., Ma, H., Li, X., Zhang, J., . . . Liu, J. CD20×CD3 bispecific antibody achieved significant efficacy in patients with large B-cell lymphoma relapsing after or refractory to CAR-T therapy: A systematic review and meta-analysis. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Shen, Jing, Jingyi Zhang, Zhengyu Zhu, Haobo Ma, Xiayan Li, Junpeng Zhang, Fan Zhou, Hua Tian, and Jinghua Liu. CD20×CD3 Bispecific Antibody Achieved Significant Efficacy in Patients with Large B-cell Lymphoma Relapsing After or Refractory to CAR-T Therapy: A Systematic Review and Meta-analysis. Frontiers Media S.A.

MLA (9th ed.) Citation

Shen, Jing, et al. CD20×CD3 Bispecific Antibody Achieved Significant Efficacy in Patients with Large B-cell Lymphoma Relapsing After or Refractory to CAR-T Therapy: A Systematic Review and Meta-analysis. Frontiers Media S.A.